Congenital lymphatic malformations

Annals of the New York Academy of Sciences

Volumn 1131, Issue , 2008, Pages 185-194

  Blei, Francine ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Hemangiomas; Lymphatic malformations; Vascular malformations; Vasculogenesis

Indexed keywords

ALCOHOL; ALPHA INTERFERON; BLEOMYCIN; DOXYCYCLINE; MEDIUM CHAIN TRIACYLGLYCEROL; PICIBANIL; SEROTONIN AGONIST; TETRADECYL SULFATE SODIUM;

ANGIOGENESIS; CONFERENCE PAPER; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE COURSE; DRUG ABSORPTION; DRUG BINDING; DRUG EXCRETION; DRUG METABOLISM; HUMAN; LYMPHANGIOGENESIS; LYMPHANGIOMATOSIS; LYMPHATIC SYSTEM DISEASE; PARACENTESIS; PRENATAL DIAGNOSIS; SCLEROTHERAPY; THORACOCENTESIS;

EID: 44449134121     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1413.016     Document Type: Conference Paper

References (114)

1. Sabin, F. 1901. On the origin of the lymphatic system from the veins and the development of the lymph heart and thoracic duct in the pig. Am. J. Anat. 1 : 367 389.
2. Huntington, G. & C. McClure. 1908. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Anat. Rec. 2 : 1 19.
3. Karkkainen, M.J., A. Saaristo, L. Jussila, et al. 2001. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98 : 12677 12682.
4. Karkkainen, M.J., P. Haiko, K. Sainio, et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 : 74 80.
5. Jeltsch, M., A. Kaipainen, V. Joukov, et al. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 : 1423 1425.
6. Wigle, J.T., N. Harvey, M. Detmar, et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21 : 1505 1513.
7. Oliver, G. & N. Harvey. 2002. A stepwise model of the development of lymphatic vasculature. Ann. N.Y. Acad. Sci. 979 : 159 165 discussion, 188-196.
8. Yuan, L., D. Moyon, L. Pardanaud, et al. 2002. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 : 4797 4806.
9. Hirakawa, S., Y.K. Hong, N. Harvey, et al. 2003. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162 : 575 586.
10. Morisada, T., Y. Oike, Y. Yamada, et al. 2005. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105 : 4649 4656.
11. Tammela, T., T.V. Petrova & K. Alitalo. 2005. Molecular lymphangiogenesis: new players. Trends Cell Biol. 15 : 434 441.
12. Adams, R.H. & K. Alitalo. 2007. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8 : 464 478.
13. Podgrabinska, S., P. Braun, P. Velasco, et al. 2002. Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. USA 99 : 16069 16074.
14. Ch'ng, S. & S.T. Tan. 2007. Pr08 lymphatic malformations and the molecular basis of lymphangiogenesis. Aust. N.Z. J. Surg. 77 (Suppl 1 A63.
15. Makinen, T. & K. Alitalo. 2002. Molecular mechanisms of lymphangiogenesis. Cold Spring Harb. Symp. Quant. Biol. 67 : 189 196.
16. Jeltsch, M., T. Tammela, K. Alitalo & J. Wilting. 2003. Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res. 314 : 69 84.
17. Oliver, G. 2004. Lymphatic vasculature development. Nat. Rev. Immunol. 4 : 35 45.
18. Oliver, G. & K. Alitalo. 2005. The lymphatic vasculature: recent progress and paradigms. Annu. Rev. Cell Dev. Biol. 21 : 457 483.
19. Stacker, S.A., R.H. Farnsworth, T. Karnezis, et al. 2007. Molecular pathways for lymphangiogenesis and their role in human disease. Novartis. Found. Symp. 281 : 38 43 discussion, 44-53, 208-209.
20. Wilting, J., M. Papoutsi, B. Christ, et al. 2002. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J. 16 : 1271 1273.
21. Huang, H.Y., C.C. Ho, P.H. Huang & S.M. Hsu. 2001. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma: implication in autocrine or paracrine regulation of lymphangioma. Lab. Invest. 81 : 1729 1734.
22. Banerji, S., J. Ni, S.X. Wang, et al. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 : 789 801.
23. Xu, H., J.R. Edwards, O. Espinosa, et al. 2004. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum. Pathol. 35 : 857 861.
24. Short, R.F., W.E. Shiels, 2nd., T.J. Sferra, et al. 2007. Site-specific induction of lymphatic malformations in a rat model for image-guided therapy. Pediatr. Radiol. 37 : 530 534.
25. Kasten, P., G. Schnoink, A. Bergmann, et al. 2007. Similarities and differences of human and experimental mouse lymphangiomas. Dev. Dyn. 236 : 2952 2961.
26. Fonkalsrud, E.W. 1994. Congenital malformations of the lymphatic system. Semin. Pediatr. Surg. 3 : 62 69.
27. Kim, J., D. Han, C.H. Hong, et al. 2005. Colonic lymphangiomatosis associated with protein-losing enteropathy. Dig. Dis. Sci. 50 : 1747 1753.
28. Azizkhan, R.G., M.J. Rutter, R.T. Cotton, et al. 2006. Lymphatic malformations of the tongue base. J. Pediatr. Surg. 41 : 1279 1284.
29. Lakshman, R. & A. Finn. 2000. Lymphopenia in lymphatic malformations. Arch. Dis. Child. 83 : 276.
30. de Serres, L.M., K.C. Sie & M.A. Richardson. 1995. Lymphatic malformations of the head and neck: a proposal for staging. Arch. Otolaryngol. Head Neck. Surg. 121 : 577 582.
31. Hamoir, M., I. Plouin-Gaudon, P. Rombaux, et al. 2001. Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck 23 : 326 337.
32. Fageeh, N., J. Manoukian, T. Tewfik, et al. 1997. Management of head and neck lymphatic malformations in children. J. Otolaryngol. 26 : 253 258.
33. Smith, R.J. 2004. Lymphatic malformations. Lymphat. Res. Biol. 2 : 25 31.
34. Chang, J.C. & T.T. Sun. 1990. Ultrasonographic diagnosis of fetal cystic hygroma. Changgeng Yi Xue Za Zhi. 13 : 214 220.
35. Haeusler, M.C., H.M. Hofmann, W. Hoenigl, et al. 1990. Congenital generalized cystic lymphangiomatosis diagnosed by prenatal ultrasound. Prenat. Diagn. 10 : 617 621.
36. Descamps, P., O. Jourdain, C. Paillet, et al. 1997. Etiology, prognosis and management of nuchal cystic hygroma: 25 new cases and literature review. Eur. J. Obstet. Gynecol. Reprod. Biol. 71 : 3 10.
37. Tanriverdi, H.A., A.K. Ertan, H.J. Hendrik, et al. 2005. Outcome of cystic hygroma in fetuses with normal karyotypes depends on associated findings. Eur. J. Obstet. Gynecol. Reprod. Biol. 118 : 40 46.
38. Ganapathy, R., M. Guven, F. Sethna, et al. 2004. Natural history and outcome of prenatally diagnosed cystic hygroma. Prenat. Diagn. 24 : 965 968.
39. Howarth, E.S., E.S. Draper, J.L. Budd, et al. 2005. Population-based study of the outcome following the prenatal diagnosis of cystic hygroma. Prenat. Diagn. 25 : 286 291.
40. Ogita, K., S. Suita, T. Taguchi, et al. 2001. Outcome of fetal cystic hygroma and experience of intrauterine treatment. Fetal Diagn. Ther. 16 : 105 110.
41. Kuwabara, Y., R. Sawa, Y. Otsubo, et al. 2004. Intrauterine therapy for the acutely enlarging fetal cystic hygroma. Fetal Diagn. Ther. 19 : 191 194.
42. Chen, M., C.P. Chen, J.C. Shih, et al. 2005. Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis. Fetal Diagn. Ther. 20 : 309 315.
43. Stevenson, D.A., T.J. Pysher, R.M. Ward & J.C. Carey. 2006. Familial congenital non-immune hydrops, chylothorax, and pulmonary lymphangiectasia. Am. J. Med. Genet. A. 140 : 368 372.
44. Moerman, P., K. Vandenberghe, H. Devlieger, et al. 1993. Congenital pulmonary lymphangiectasis with chylothorax: a heterogeneous lymphatic vessel abnormality. Am. J. Med. Genet. 47 : 54 58.
45. Bellini, C., M. Mazzella, C. Arioni, et al. 2003. Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am. J. Med. Genet. A 120 : 92 96.
46. Bellini, C., F. Boccardo, C. Campisi & E. Bonioli. 2006. Congenital pulmonary lymphangiectasia. Orphanet. J. Rare Dis. 1 : 43.
47. Wilson, R.D., B. Pawel, M. Bebbington, et al. 2006. Congenital pulmonary lymphangiectasis sequence: a rare, heterogeneous, and lethal etiology for prenatal pleural effusion. Prenat. Diagn. 26 : 1058 1061.
48. Farrell, P.T. 2004. Prenatal diagnosis and intrapartum management of neck masses causing airway obstruction. Paediatr. Anaesth. 14 : 48 52.
49. Rahbar, R., A. Vogel, L.B. Myers, et al. 2005. Fetal surgery in otolaryngology: a new era in the diagnosis and management of fetal airway obstruction because of advances in prenatal imaging. Arch. Otolaryngol. Head Neck. Surg. 131 : 393 398.
50. Kuczkowski, K.M. 2007. Advances in obstetric anesthesia: anesthesia for fetal intrapartum operations on placental support. J. Anesth. 21 : 243 251.
51. Happle, R. 1987. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J. Am. Acad. Dermatol. 16 : 899 906.
52. Schwartz, C.E., A.M. Brown, V.M. Der Kaloustian, et al. 1991. DNA fingerprinting: the utilization of minisatellite probes to detect a somatic mutation in the Proteus syndrome. EXS 58 : 95 105.
53. Hamm, H. 1999. Cutaneous mosaicism of lethal mutations. Am. J. Med. Genet. 85 : 342 345.
54. Erickson, R.P. 2003. Somatic gene mutation and human disease other than cancer. Mutat. Res. 543 : 125 136.
55. Maari, C. & I.J. Frieden. 2004. Klippel-Trenaunay syndrome: the importance of "geographic stains" in identifying lymphatic disease and risk of complications. J. Am. Acad. Dermatol. 51 : 391 398.
56. Tian, X.L., R. Kadaba, S.A. You, et al. 2004. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427 : 640 645.
57. Timur, A.A., D.J. Driscoll & Q. Wang. 2005. Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol. Life Sci. 62 : 1434 1447.
58. Timur, A.A., A. Sadgephour, M. Graf, et al. 2004. Identification and molecular characterization of a de novo supernumerary ring chromosome 18 in a patient with Klippel-Trenaunay syndrome. Ann. Hum. Genet. 68 (Pt 4 353 361.
59. Wang, Q., A.A. Timur, P. Szafranski, et al. 2001. Identification and molecular characterization of de novo translocation t(8;14)(q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet. Cell. Genet. 95 : 183 188.
60. Wang, Q.K. 2005. Update on the molecular genetics of vascular anomalies. Lymphat. Res. Biol. 3 : 226 233.
61. Cardoso, M.T., T.B. de Carvalho, L.A. Casulari & I. Ferrari. 2003. Proteus syndrome and somatic mosaicism of the chromosome 16. Panminerva Med. 45 : 267 271.
62. Thiffault, I., C.E. Schwartz, V. Der Kaloustian & W.D. Foulkes. 2004. Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am. J. Med. Genet. A 130 : 123 127.
63. Cohen, M.M., Jr. 2005. Proteus syndrome: an update. Am. J. Med. Genet. C Semin. Med. Genet. 137 : 38 52.
64. Loffeld, A., N.J. McLellan, T. Cole, et al. 2006. Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation. Br. J. Dermatol. 154 : 1194 1198.
65. Caux, F., H. Plauchu, F. Chibon, et al. 2007. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur. J. Hum. Genet. 15 : 767 773.
66. Gorham, L.W. & A.P. Stout. 1954. Hemangiomatosis and its relation to massive osteolysis. Trans. Assoc. Am. Physicians. 67 : 302 307.
67. Gorham, L.W. & A.P. Stout. 1955. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J. Bone. Joint. Surg. Am. 37-A : 985 1004.
68. Heyden, G., L.G. Kindblom & J.M. Nielsen. 1977. Disappearing bone disease: a clinical and histological study. J. Bone. Joint. Surg. Am. 59 : 57 61.
69. Patel, D.V. 2005. Gorham's disease or massive osteolysis. Clin. Med. Res. 3 : 65 74.
70. Dickson, G.R., R.A. Mollan & K.E. Carr. 1987. Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry 87 : 569 572.
71. Devlin, R.D., H.G. Bone, 3rd & G.D. Roodman. 1996. Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J. Clin. Endocrinol. Metab. 81 : 1893 1897.
72. Hirayama, T., A. Sabokbar, I. Itonaga, et al. 2001. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J. Pathol. 195 : 624 630.
73. Hagendoorn, J., T.P. Padera, T.I. Yock, et al. 2006. Platelet-derived growth factor receptor-beta in Gorham's disease. Nat. Clin. Pract. Oncol. 3 : 693 697.
74. Lee, J. & M.S. Kong. 2007. Primary intestinal lymphangiectasia diagnosed by endoscopy following the intake of a high-fat meal. Eur. J. Pediatr. 167 : 237 239.
75. Rivet, C., M.G. Lapalus, J. Dumortier, et al. 2006. Use of capsule endoscopy in children with primary intestinal lymphangiectasia. Gastrointest. Endosc. 64 : 649 650.
76. Chamouard, P., H. Nehme-Schuster, J.M. Simler, et al. 2006. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Dig. Liver. Dis. 38 : 699 703.
77. Danielsson, A., E. Toth & H. Thorlacius. 2006. Capsule endoscopy in the management of a patient with a rare syndrome-yellow nail syndrome with intestinal lymphangiectasia. Gut 55 : 196 233.
78. Cammarota, G., R. Cianci & G. Gasbarrini. 2005. High-resolution magnifying video endoscopy in primary intestinal lymphangiectasia: a new role for endoscopy? Endoscopy 37 : 607.
79. Timke, C., M.F. Krause, H.C. Oppermann, et al. 2007. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr. Blood Can. 48 : 108 111.
80. Rostom, A.Y. 2000. Treatment of thoracic lymphangiomatosis. Arch. Dis. Child. 83 : 138 139.
81. Kandil, A., A.Y. Rostom, W.A. Mourad, et al. 1997. Successful control of extensive thoracic lymphangiomatosis by irradiation. Clin. Oncol. (R. Coll. Radiol.) 9 : 407 411.
82. Kuroiwa, G., T. Takayama, Y. Sato, et al. 2001. Primary intestinal lymphangiectasia successfully treated with octreotide. J. Gastroenterol. 36 : 129 132.
83. Klingenberg, R.D., N. Homann & D. Ludwig. 2003. Type I intestinal lymphangiectasia treated successfully with slow-release octreotide. Dig. Dis. Sci. 48 : 1506 1509.
84. Filik, L., P. Oguz, A. Koksal, et al. 2004. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide. Dig. Liver Dis. 36 : 687 690.
85. te Pas, A.B., K. vd Ven, M.P. Stokkel & F.J. Walther. 2004. Intractable congenital chylous ascites. Acta Paediatr. 93 : 1403 1405.
86. Makhija, S., P.Y. von der Weid, J. Meddings, et al. 2004. Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model. Can. J. Gastroenterol. 18 : 681 685.
87. Raveh, E., A.L. de Jong, G.P. Taylor & V. Forte. 1997. Prognostic factors in the treatment of lymphatic malformations. Arch. Otolaryngol. Head Neck. Surg. 123 : 1061 1065.
88. Padwa, B.L., P.G. Hayward, N.F. Ferraro & J.B. Mulliken. 1995. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and of skeletal hypertrophy. Plast. Reconstr. Surg. 95 : 951 960.
89. Lei, Z.M., X.X. Huang, Z.J. Sun, et al. 2007. Surgery of lymphatic malformations in oral and cervicofacial regions in children. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 104 : 338 344.
90. Fishman, S.J., P.E. Burrows, J. Upton & W.H. Hendren. 2001. Life-threatening anomalies of the thoracic duct: anatomic delineation dictates management. J. Pediatr. Surg. 36 : 1269 1272.
91. Barrier, A., F. Lacaine, P. Callard & M. Huguier. 2002. Lymphangiomatosis of the spleen and 2 accessory spleens. Surgery 131 : 114 116.
92. Sung, M.W., S.O. Chang, J.H. Choi & J.Y. Kim. 1995. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am. J. Otolaryngol. 16 : 236 241.
93. Molitch, H.I., E.C. Unger, C.L. Witte & E. van Sonnenberg. 1995. Percutaneous sclerotherapy of lymphangiomas. Radiology 194 : 343 347.
94. Kim, K.H., M.W. Sung, J.L. Roh & M.H. Han. 2004. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol. Head. Neck. Surg. 131 : 307 316.
95. Ogita, S., T. Tsuto, K. Tokiwa & T. Takahashi. 1987. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br. J. Surg. 74 : 690 691.
96. Ogita, S., T. Tsuto, E. Deguchi, et al. 1991. OK-432 therapy for unresectable lymphangiomas in children. J. Pediatr. Surg. 26 : 263 268 discussion, 268-270.
97. Ogita, S., T. Tsuto, K. Nakamura, et al. 1996. OK-432 therapy for lymphangioma in children: why and how does it work? J. Pediatr. Surg. 31 : 477 480.
98. Ogita, S., T. Tsuto, K. Nakamura, et al. 1994. OK-432 therapy in 64 patients with lymphangioma. J. Pediatr. Surg. 29 : 784 785.
99. Giguere, C.M., N.M. Bauman, Y. Sato, et al. 2002. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch. Otolaryngol. Head Neck Surg. 128 : 1137 1144.
100. Greinwald, J.H., Jr., D.K. Burke, Y. Sato, et al. 1999. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Arch. Otolaryngol. Head Neck Surg. 121 : 381 387.
101. Smith, R.J., D.K. Burke, Y. Sato, et al. 1996. OK-432 therapy for lymphangiomas. Arch. Otolaryngol. Head Neck. Surg. 122 : 1195 1199.
102. Peters, D.A., D.J. Courtemanche, M.K. Heran, et al. 2006. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast. Reconstr. Surg. 118 : 1441 1446.
103. Alomari, A.I., V.E. Karian, D.J. Lord, et al. 2006. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J. Vasc. Interv. Radiol. 17 : 1639 1648.
104. Reinhardt, M.A., S.C. Nelson, S.F. Sencer, et al. 1997. Treatment of childhood lymphangiomas with interferon-alpha. J. Pediatr. Hematol. Oncol. 19 : 232 236.
105. Ozeki, M., M. Funato, K. Kanda, et al. 2007. Clinical improvement of diffuse lymphangiomatosis with pegylated interferon alfa-2b therapy: case report and review of the literature. Pediatr. Hematol. Oncol. 24 : 513 524.
106. Bisdorff, A., J.B. Mulliken, J. Carrico, et al. 2007. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am. J. Neuroradiol. 28 : 335 341.
107. Chen, Y.L., C.C. Lee, M.L. Yeh, et al. 2007. Generalized lymphangiomatosis presenting as cardiomegaly. J. Formos. Med. Assoc. 106 (3 Suppl S10 14.
108. Tamay, Z., E. Saribeyoglu, U. Ones, et al. 2005. Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child. J. Pediatr. Hematol. Oncol. 27 : 685 687.
109. Garzon, M.C., J.T. Huang, O. Enjolras & I.J. Frieden. 2007. Vascular malformations. Part II. Associated syndromes. J. Am. Acad. Dermatol. 56 : 541 564.
110. Van Balkom, I.D., M. Alders, J. Allanson, et al. 2002. Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am. J. Med. Genet. 112 : 412 421.
111. Van Der Burgt, I. 2007. Noonan syndrome. Orphanet. J. Rare. Dis. 2 : 4.
112. Keberle, M., H. Mork, M. Jenett, et al. 2000. Computed tomography after lymphangiography in the diagnosis of intestinal lymphangiectasia with protein-losing enteropathy in Noonan's syndrome. Eur. Radiol. 10 : 1591 1593.
113. von Kaisenberg, C.S., K.H. Nicolaides & B. Brand-Saberi. 1999. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum. Reprod. 14 : 823 826.
114. Ochiai, M., S. Hikino, H. Nakayama, et al. 2006. Nonimmune hydrops fetalis due to generalized lymphatic dysplasia in an infant with Robertsonian trisomy 21. Am. J. Perinatol. 23 : 63 66.